Home » Structural Heart Devices Market

Structural Heart Devices Market By Type (Heart Valve Devices, Repair Devices, Accessories), By Procedure (Repair Procedures, Replacement Procedures) – Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Price: $4999

Published: | Report ID: 9892 | Report Format : PDF

Industry Outlook

Over the past three decades, several transcatheter technologies and devices for surgical interventions in structural heart diseases have been introduced to the market. There are several technologies currently under development that use transcatheter intervention techniques. The expansion of percutaneous treatment approaches has resulted in the evolution of clinical care. The previous few years have also witnessed the greater application of new catheter-based treatments for structural heart disease. Several of these interventional procedures have excellent clinical outcomes, therefore gaining greater acceptance among patients and surgeons alike. Advanced imaging technologies have aided in the rapid penetration of minimally invasive interventions for the treatment of structural heart diseases. The introduction of novel imaging technologies has assisted in the precise identification and diagnosis of structural heart diseases for appropriate patient selection for different intervention procedures.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Market Synopsis

Greater demand for heart valve devices is expected to be prominently witnessed during the forecast period.

Based on the type of devices, the global structural heart devices market is segmented into heart valve devices, repair devices, and accessories. Among these, the demand for heart valve devices is set to remain the highest during the forecast period. The market for heart valve devices is significantly large and rapidly growing. It is mainly driven by the continuous adoption and commercialization of new devices and the rapidly growing pool of geriatric cardiovascular disease-affected populations. Increasing amounts of positive clinical evidence are also supporting the demand for heart valve devices. Furthermore, the competitive landscape of this segment is constantly shifting, with small innovator companies being acquired on a regular basis by cash-rich and established market players. The pipeline of heart valve devices is also observed to be strong, with new, long-lasting devices anticipated to be introduced in the coming years.

Replacement procedures will have the highest CAGR during the forecast period.

On the basis of procedure types, this market is categorized into repair and replacement procedures. The repair procedures segment is further segmented into valvuloplasty, transcatheter mitral valve repair (TMVR), annuloplasty, and others, whereas the replacement procedures segment is studied for tissue heart valves, mechanical heart valves, and transcatheter aortic valve replacement (TAVR). The demand for replacement procedures is anticipated to be the highest during the forecast period. The key factor attributed to the growth of this segment is consistent growth in the geriatric population with high vulnerability to debilitating cardiovascular diseases. Improved long-term durability, the growing uptake of minimally invasive and transcatheter procedures, and competitive prices of replacement devices further drive the growth of this segment.

North America will dominate the global structural heart devices market.

Significantly high disease incidence, the rapid introduction of novel, breakthrough repair and replacement devices and procedures, along with favorable reimbursements for the already established procedures are the key factors driving the dominance of the North American market on the global front. Additionally, this region is also characterized by the domicile of the major market incumbents, therefore ensuring the early introduction of novel devices in the market. Asia Pacific, on the other hand, is expected to witness the fastest market growth during the forecast period. Increasing regulatory approvals, improving reimbursements, and the growing involvement of government funding in public healthcare are collectively driving the Asia-Pacific market. Recognizing such opportunities, market players with a stronghold in developed regions are expanding their footprints in Asia-Pacific. Distribution agreements, the establishment of manufacturing facilities, and research collaborations are the key strategic events observed in the region.

Periods of History and Forecast

This research report presents the analysis of each considered segment for the period from 2016 to 2026, using 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The structural heart devices market report provides a quantitative assessment of the industry in terms of current and forecasted market size while also presenting the market dynamics. This market is segmented based on device type, procedure, and geography.

As mentioned, this report offers market size and forecasts for each market segment considered in the study scope for the period from 2016 to 2026. Furthermore, quantitative information sets for each such segment are provided in the study for better market analysis. Analytical factors such as drivers, challenges, and opportunities are also covered in this report. In addition, this report provides profiles of key players operating in this market, such as Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic PLC, LivaNova PLC, C. R. Bard, Inc., CryoLife, Inc., Integer Holdings Corporation, Comed B.V., and JenaValve Technology, Inc.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key questions are answered in this report.

  • What are the most promising growth opportunities and drivers prevailing in the global structural heart devices market?
  • Which product segment is estimated to generate the largest revenue?
  • What are the major factors influencing global market growth during the forecast period?
  • Who are the major players operating in the global structural heart devices market, and which companies are bingeing on the latest developments in the industry?
  • Which are the key competing products in the global market for structural heart devices?
  • Which region will progress with the fastest growth rate during the forecast period?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global SHD Market Portraiture
2.2. Global SHD Market, by Type, 2017 (US$ Mn)
2.3. Global SHD Market, by Procedure, 2017 (US$ Mn)
2.4. Global SHD Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Structural Heart Devices (SHD) Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global SHD Market, by Key Players, 2017

Chapter 4. Global Structural Heart Devices (SHD) Market, by Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Heart Valve Devices
4.2.1. Surgical Heart Valves
4.2.2. Transcatheter Heart Valves
4.3. Repair Devices
4.3.1. Occluders and Delivery Systems
4.3.2. Annuloplasty Rings
4.3.3. Others
4.4. Accessories

Chapter 5. Global Structural Heart Devices (SHD) Market, by Procedure, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Repair Procedures
5.2.1. Valvuloplasty
5.2.2. Transcatheter Mitral Valve Repair (TMVR)
5.2.3. Annuloplasty
5.2.4. Others
5.3. Replacement Procedures
5.3.1. Tissue Heart Valves
5.3.2. Mechanical Heart Valves
5.3.3. Transcatheter Aortic Valve Replacement (TAVR)

Chapter 6. Global Structural Heart Devices (SHD) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America SHD Market, 2016 – 2026 (US$ Mn)
6.2.1. North America SHD Market, by Type, 2016 – 2026 (US$ Mn)
6.2.2. North America SHD Market, by Procedure, 2016 – 2026 (US$ Mn)
6.2.3. North America SHD Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe SHD Market, 2016 – 2026 (US$ Mn)
6.3.1. Europe SHD Market, by Type, 2016 – 2026 (US$ Mn)
6.3.2. Europe SHD Market, by Procedure, 2016 – 2026 (US$ Mn)
6.3.3. Europe SHD Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific SHD Market, 2016 – 2026 (US$ Mn)
6.4.1. Asia Pacific SHD Market, by Type, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific SHD Market, by Procedure, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific SHD Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America SHD Market, 2016 – 2026 (US$ Mn)
6.5.1. Latin America SHD Market, by Type, 2016 – 2026 (US$ Mn)
6.5.2. Latin America SHD Market, by Procedure, 2016 – 2026 (US$ Mn)
6.5.3. Latin America SHD Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa SHD Market, 2016 – 2026 (US$ Mn)
6.6.1. Middle East & Africa SHD Market, by Type, 2016 – 2026 (US$ Mn)
6.6.2. Middle East & Africa SHD Market, by Procedure, 2016 – 2026 (US$ Mn)
6.6.3. Middle East & Africa SHD Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of Middle East & Africa

Chapter 7. Company Profiles
7.1. Abbott Laboratories
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Boston Scientific Corporation
7.3. Edwards Lifesciences Corporation
7.4. Medtronic PLC
7.5. LivaNova PLC
7.6. C. R. Bard, Inc.
7.7. CryoLife, Inc.
7.8. Integer Holdings Corporation
7.9. Comed B.V.
7.10. JenaValve Technology, Inc.

List of Figures

FIG 1. Structural Heart Devices (SHD) Market: Research Methodology
FIG 2. Market Size Estimation – Top Down & Bottom up Approach
FIG 3. SHD Market Segmentation
FIG 4. Global SHD Market, by Type, 2017 (US$ Mn)
FIG 5. Global SHD Market, by Procedure, 2017 (US$ Mn)
FIG 6. Global SHD Market, by Geography, 2017 (US$ Mn)
FIG 7. Attractive Investment Proposition, by Geography, 2017
FIG 8. Competitive Analysis: Global SHD Market, by Key Players, 2017
FIG 9. Global Surgical Heart Valves Market, 2016 – 2026 (US$ Mn)
FIG 10. Global Transcatheter Heart Valves Market, 2016 – 2026 (US$ Mn)
FIG 11. Global Occluders and Delivery Systems Market, 2016 – 2026 (US$ Mn)
FIG 12. Global Annuloplasty Rings Market, 2016 – 2026 (US$ Mn)
FIG 13. Global Other Repair Devices Market, 2016 – 2026 (US$ Mn)
FIG 14. Global Structural Heart Accessories Market, 2016 – 2026 (US$ Mn)
FIG 15. Global SHD Market for Valvuloplasty, 2016 – 2026 (US$ Mn)
FIG 16. Global SHD Market for Transcatheter Mitral Valve Repair (TMVR), 2016 – 2026 (US$ Mn)
FIG 17. Global SHD Market for Annuloplasty, 2016 – 2026 (US$ Mn)
FIG 18. Global SHD Market for Other Repair Procedures, 2016 – 2026 (US$ Mn)
FIG 19. Global SHD Market for Tissue Heart Valves, 2016 – 2026 (US$ Mn)
FIG 20. Global SHD Market for Mechanical Heart Valves, 2016 – 2026 (US$ Mn)
FIG 21. Global SHD Market for Transcatheter Aortic Valve Replacement (TAVR), 2016 – 2026 (US$ Mn)
FIG 22. U.S. SHD Market, 2016 – 2026 (US$ Mn)
FIG 23. Canada SHD Market, 2016 – 2026 (US$ Mn)
FIG 24. U.K. SHD Market, 2016 – 2026 (US$ Mn)
FIG 25. Germany SHD Market, 2016 – 2026 (US$ Mn)
FIG 26. Rest of Europe SHD Market, 2016 – 2026 (US$ Mn)
FIG 27. China SHD Market, 2016 – 2026 (US$ Mn)
FIG 28. Japan SHD Market, 2016 – 2026 (US$ Mn)
FIG 29. India SHD Market, 2016 – 2026 (US$ Mn)
FIG 30. Rest of Asia Pacific SHD Market, 2016 – 2026 (US$ Mn)
FIG 31. Brazil SHD Market, 2016 – 2026 (US$ Mn)
FIG 32. Mexico SHD Market, 2016 – 2026 (US$ Mn)
FIG 33. Rest of Latin America SHD Market, 2016 – 2026 (US$ Mn)
FIG 34. GCC SHD Market, 2016 – 2026 (US$ Mn)
FIG 35. Rest of Middle East and Africa SHD Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Structural Heart Devices (SHD) Market Portraiture
TABLE 2 Global SHD Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Heart Valve Devices Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global Structural Heart Repair Devices Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 5 Global SHD Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 6 Global SHD Market, by Repair Procedure, 2016 – 2026 (US$ Mn)
TABLE 7 Global SHD Market, by Replacement Procedure, 2016 – 2026 (US$ Mn)
TABLE 8 Global SHD Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 9 North America SHD Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 10 North America SHD Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 11 North America SHD Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 12 Europe SHD Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 13 Europe SHD Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 14 Europe SHD Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 Asia Pacific SHD Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 16 Asia Pacific SHD Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 17 Asia Pacific SHD Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 18 Latin America SHD Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 19 Latin America SHD Market, by Procedure, 2016 – 2026 (US$ Mn
TABLE 20 Latin America SHD Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 21 Middle East and Africa SHD Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 22 Middle East and Africa SHD Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 23 Middle East and Africa SHD Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 24 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Edwards Lifesciences Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Medtronic PLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 LivaNova PLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 C. R. Bard, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 CryoLife, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Integer Holdings Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 Comed B.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 JenaValve Technology, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Frequently Asked Questions:

What is the size of Structural Heart Devices Market?

The market for Structural Heart Devices Market is expected to reach US$ XX Mn by 2026.

What is the Structural Heart Devices Market CAGR?

The Structural Heart Devices Market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for Structural Heart Devices Market?

The report is forecasted from 2018-2026.

What is the base year considered for Structural Heart Devices Market?

The base year of this report is 2017.

Who are the major players in this market?

Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic PLC, LivaNova PLC, C. R. Bard, Inc., CryoLife, Inc., Integer Holdings Corporation, Comed B.V. are some of the major players in the global market.

Medical Robotics Market

Published:
Report ID: 14075

Ablation Devices Market

Published:
Report ID: 1062

Medical Imaging Reagents Market

Published:
Report ID: 8770

X-Ray Security Screening Market

Published:
Report ID: 9312

Metal Implants and Medical Alloys Market

Published:
Report ID: 32899

Venous Thromboembolism (VTE) Treatment Market

Published:
Report ID: 11666

X-Ray Equipment Market

Published:
Report ID: 9306

In-Vitro Diagnostics (IVD) Market

Published:
Report ID: 6408

Standalone Intraoral Scanners Market

Published:
Report ID: 9690

Healthcare Analytical Testing Market

Published:
Report ID: 7179

Iron Deficiency Injectable Market

Published:
Report ID: 32525

Fixed and Mobile C Arms Market

Published:
Report ID: 32518

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


support

24/7 Research Support


– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN